Targeting the PI3K/AKT/mTOR pathway in epithelial ovarian cancer, therapeutic treatment options for platinum-resistant ovarian cancer

The survival rates for women with ovarian cancer have shown scant improvement in recent years, with a 5-year survival rate of less than 40% for women diagnosed with advanced ovarian cancer. High-grade serous ovarian cancer (HGSOC) is the most lethal subtype where the majority of women develop recurr...

Descripción completa

Detalles Bibliográficos
Autores principales: Rinne, Natasha, Christie, Elizabeth L., Ardasheva, Anastasia, Kwok, Chun Hei, Demchenko, Nikita, Low, Caroline, Tralau-Stewart, Catherine, Fotopoulou, Christina, Cunnea, Paula
Formato: Online Artículo Texto
Lenguaje:English
Publicado: OAE Publishing Inc. 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019160/
https://www.ncbi.nlm.nih.gov/pubmed/35582310
http://dx.doi.org/10.20517/cdr.2021.05

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9019160/
https://www.ncbi.nlm.nih.gov/pubmed/35582310
http://dx.doi.org/10.20517/cdr.2021.05

Ejemplares similares